APA

Zawiah M., Yousef A., Kadi T., Yousef M., Majdalawi K., Al-Yacoub S., Al-Hiary R., Tantawi D., Mukred R. & Ajaj A. R. (20190617). Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. : Drug metabolism and personalized therapy.

Chicago

Zawiah Mohammed, Yousef Al-Motassem, Kadi Taha, Yousef Mohammed, Majdalawi Khalil, Al-Yacoub Shorouq, Al-Hiary Rasha, Tantawi Dua'a, Mukred Ramzi and Ajaj Abdel Rahman. 20190617. Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. : Drug metabolism and personalized therapy.

Harvard

Zawiah M., Yousef A., Kadi T., Yousef M., Majdalawi K., Al-Yacoub S., Al-Hiary R., Tantawi D., Mukred R. and Ajaj A. R. (20190617). Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. : Drug metabolism and personalized therapy.

MLA

Zawiah Mohammed, Yousef Al-Motassem, Kadi Taha, Yousef Mohammed, Majdalawi Khalil, Al-Yacoub Shorouq, Al-Hiary Rasha, Tantawi Dua'a, Mukred Ramzi and Ajaj Abdel Rahman. Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. : Drug metabolism and personalized therapy. 20190617.